China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020)
China Pharma Holdings' (CPHI) quarterly Change in Taxes came in at -$155827.0 in Q3 2020, down 332.74% on a YoY basis from $66953.0 in Q4 2019, and down 168.57% quarter-over-quarter from $227245.0 in Q2 2020.
Powered by 
Analysis
China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020) Analysis & Trends
China Pharma Holdings (CPHI) has reported Change in Taxes for 11 consecutive years, with -$155827.0 the latest figure, recorded in Q3 2020.
- For the quarter ending Q3 2020, Change in Taxes fell 332.74% year-over-year to -$155827.0; the trailing twelve-month figure through Sep 2020 stood at $113571.0 (up 1315.18% YoY), and the FY2019 full-year result was $12971.0, up 108.82% from the prior year.
- Change in Taxes retreated to -$155827.0 in Q3 2020 per CPHI's latest filing, from $227245.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $227245.0 in Q2 2020 and bottomed at -$163335.0 in Q1 2018.
- Historically, Change in Taxes has averaged $4244.9 across 5 years, with a median of -$10350.0 in 2019.
- The sharpest annual moves came in 2017 and 2020: Change in Taxes slumped 711.18% in 2017, then surged 2655.49% in 2020.
- Over 5 years, Change in Taxes stood at $146187.0 in 2016, then plunged by 88.35% to $17034.0 in 2017, then sank by 291.78% to -$32667.0 in 2018, then surged by 68.32% to -$10350.0 in 2019, then plunged by 1405.57% to -$155827.0 in 2020.
- According to Business Quant data, Change in Taxes over the past three periods registered -$155827.0, $227245.0, and $52503.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -2.22 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -398.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -155,827.00 |
| Jun 30, 2020 | 227,245.00 |
| Mar 31, 2020 | 52,503.00 |
| Dec 31, 2019 | -10,350.00 |
| Sep 30, 2019 | 66,953.00 |
| Jun 30, 2019 | 8,247.00 |
| Mar 31, 2019 | -51,879.00 |
| Dec 31, 2018 | -32,667.00 |
| Sep 30, 2018 | -20,016.00 |
| Jun 30, 2018 | 68,919.00 |
| Mar 31, 2018 | -163,335.00 |
| Dec 31, 2017 | 17,034.00 |
| Sep 30, 2017 | 146,458.00 |
| Jun 30, 2017 | -73,164.00 |
| Mar 31, 2017 | -71,575.00 |
| Dec 31, 2016 | 146,187.00 |
| Sep 30, 2016 | -32,096.00 |
| Jun 30, 2016 | 11,971.00 |
| Mar 31, 2016 | -53,955.00 |
| Dec 31, 2015 | -616,770.00 |